Frontiers in Cancer Science—the Singapore Cancer Conference
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
In 2008, Robin Evans received a devastating diagnosis: stage 4 metastatic triple-negative breast cancer. This subtype of breast cancer,...
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
Black Americans are more than twice as likely to die from prostate cancer than white Americans, highlighting a major...
Although a basic assumption of genetics is that all the cells in our body share the same DNA, research...
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...